AGP Executive Report

Last update: 9 hours ago

Food Safety: Hong Kong authorities warned against eating a recalled batch of French Camembert after a possible E. coli contamination; the affected 250g packs have a use-by date of October 17, 2026. Covid-19: Cases are rising in France, prompting a doctors’ union to call for vaccination to begin early. Medical Research: French chemist Henri Kagan shared the 2026 Nobel Prize in Chemistry for work that helps researchers control molecule formation—an advance with important applications in drug development. Prevention: France is considering extending its sugar tax to high-sugar processed foods. Ebola Response: France has pledged further support for efforts to fight the deadly outbreak in the Democratic Republic of Congo.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Sep. 29, 2026

bonyf updates Periocream launch in Italy and Poland, Fixobridge sales in France

AGP

fallback image
Sep. 16, 2026

Rebecca Adelman builds a risk strategy career around healthcare, senior living and women’s leadership

AGP

fallback image
Sep. 15, 2026

ABL Diagnostics to present at Paris midcap investor event

AGP

fallback image
Sep. 15, 2026

Tylent unveils Lyvra IV automation platform in France

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Press Release Service Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Press Release Service
Indeterminate

fallback image
15 hours ago

PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential breakthrough approach to treat Dry AMD/Geographic Atrophy

GlobeNewswire, Inc.

fallback image
Oct. 6, 2026

Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight

GlobeNewswire, Inc.

fallback image
Oct. 6, 2026

TISSIUM® Announces First U.S. Patients Treated with the ECLIPSIUM® System in UNITE Clinical Trial

GlobeNewswire, Inc.

fallback image
Oct. 6, 2026

OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain

GlobeNewswire, Inc.

fallback image
Oct. 6, 2026

Channel Crossing Attempt Ends in Migrant Deaths Off Northern France

MENAFN

fallback image
Oct. 2, 2026

LAST CALL - Biocodex Microbiota Foundation invites Canadian academics and scientists to apply for €35,000 ($55,000 CAD based on current exchange rate) research grant to advance microbiota research in human health & disease.

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail:  Why Are Students Protesting in France?
Play
Why Are Students Protesting in France?
YouTube video thumbnail: Police Fire Teargas as Hundreds of Thousands Join Student Protests Over Crumbling Schools
Play
Police Fire Teargas as Hundreds of Thousands Join Student Protests Over Crumbling Schools
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Frenchwoman Buys Elephants From Abusive Owners in Laos
Play
Frenchwoman Buys Elephants From Abusive Owners in Laos
YouTube video thumbnail: Schools Shut as Student Protests Shake France
Play
Schools Shut as Student Protests Shake France

Video Title

Sign up for:

Healthcare Tribune France

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Tribune France

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.